Statistics in Drug Discovery
药物发现统计
基本信息
- 批准号:0072809
- 负责人:
- 金额:$ 3.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-06-01 至 2002-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Students who are supported solely by industry are typically so involved with solving the company's daily problems that they do not have opportunities for conducting research to aid their understanding of the basic problems encountered. This project provides funding for two students so that half their time will be devoted to research on new opportunities identified through company projects and the remaining time will be devoted to working on the company's daily problems. The company identified for this project is Glaxo Wellcome (GW), with Dr. S. Stanley Young serving as industry mentor. Specific goals include developing methods for: (a) variable selection in the context of pooled data on compound potency; (b) using pooled data for elucidating the relationship between the chemical structural features of individual compounds and the probabilities that the compound will be biologically potent or will restrict biological potency; and (c) predicting the potencyof an individual compound solely based on its chemical structural features.Students will gain experience in formulating research problems, evaluating project impacts on the company's operation and on scientific research, and making oral and written presentations to individuals from different disciplines. This proposal will also impact GW's operations. Because company scientists are involved in the program, the procedures developed will be more suitable for their applications and there is a potential for the company to invent profitable products resulting from these studies. This GOALI project is jointly supported by the MPS Office of Multidisciplinary Activities (OMA) and the Division of Mathematical Sciences (DMS).
那些完全由行业支持的学生通常都在忙于解决公司的日常问题,以至于他们没有机会进行研究来帮助他们理解所遇到的基本问题。该项目为两名学生提供资金,以便他们一半的时间将用于研究通过公司项目确定的新机会,其余时间将用于解决公司的日常问题。该项目选定的公司是葛兰素惠康(GW),由S. Stanley Young博士担任行业导师。具体目标包括开发以下方法:(a)在化合物效价汇总数据的背景下进行变量选择;(b)使用汇总数据阐明单个化合物的化学结构特征与该化合物具有生物效力或限制生物效力的可能性之间的关系;(c)仅根据其化学结构特征预测单个化合物的效力。学生将获得制定研究问题,评估项目对公司运营和科研的影响,以及向不同学科的个人进行口头和书面报告的经验。这一提议也将影响GW的运营。由于公司的科学家参与了该项目,开发的程序将更适合他们的应用,并且公司有可能从这些研究中发明有利可图的产品。该GOALI项目由MPS多学科活动办公室(OMA)和数学科学司(DMS)联合支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacqueline Hughes-Oliver其他文献
Jacqueline Hughes-Oliver的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacqueline Hughes-Oliver', 18)}}的其他基金
Nonstationary Spatial Modeling for Multiple Point Sources, with Applications to Enviromnental Data
多点源的非平稳空间建模及其在环境数据中的应用
- 批准号:
0084378 - 财政年份:2000
- 资助金额:
$ 3.84万 - 项目类别:
Standard Grant
Mathematical Sciences: "Nonlinear Modeling of Spatially Correlated Data: Preliminary Investigations"
数学科学:“空间相关数据的非线性建模:初步研究”
- 批准号:
9631877 - 财政年份:1996
- 资助金额:
$ 3.84万 - 项目类别:
Standard Grant
相似国自然基金
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
- 批准号:61372188
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
- 批准号:61073135
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:面上项目
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
- 批准号:20776012
- 批准年份:2007
- 资助金额:31.0 万元
- 项目类别:面上项目
用Drug-Western法分离恶性疟原虫cDNA编码的青蒿素类药物结合蛋白
- 批准号:30070681
- 批准年份:2000
- 资助金额:14.0 万元
- 项目类别:面上项目
相似海外基金
I-Corps: Translation Potential of a High Throughput Drug Discovery Platform for Protein Degraders
I-Corps:蛋白质降解剂高通量药物发现平台的转化潜力
- 批准号:
2419488 - 财政年份:2024
- 资助金额:
$ 3.84万 - 项目类别:
Standard Grant
FMO/ML-Guided Drug Design: Accelerating Novel Inhibitor Development and Drug Discovery
FMO/ML 引导的药物设计:加速新型抑制剂的开发和药物发现
- 批准号:
24K20888 - 财政年份:2024
- 资助金额:
$ 3.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Creating an intracellular screening platform for cyclic peptide drug discovery
创建用于环肽药物发现的细胞内筛选平台
- 批准号:
EP/Z533002/1 - 财政年份:2024
- 资助金额:
$ 3.84万 - 项目类别:
Research Grant
SBIR Phase I: High-Throughput Direct Ratiometric Calorimeter for Drug Discovery
SBIR 第一阶段:用于药物发现的高通量直接比率量热仪
- 批准号:
2402322 - 财政年份:2024
- 资助金额:
$ 3.84万 - 项目类别:
Standard Grant
Discovery-Driven Mathematics and Artificial Intelligence for Biosciences and Drug Discovery
用于生物科学和药物发现的发现驱动数学和人工智能
- 批准号:
10551576 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Accelerating drug discovery via ML-guided iterative design and optimization
通过机器学习引导的迭代设计和优化加速药物发现
- 批准号:
10552325 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Mass spectrometry approaches to address capability gaps in drug discovery for membrane transporters
质谱方法可解决膜转运蛋白药物发现中的能力差距
- 批准号:
2877802 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Studentship
Tackling the pandemic of antibiotic-resistant infections: An artificial intelligence approach to new druggable therapeutic targets and drug discovery
应对抗生素耐药性感染的流行:利用人工智能方法实现新的药物治疗靶点和药物发现
- 批准号:
MR/X009246/1 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Research Grant
Development of phage technology to precise control of intestinal microbiota disturbance for novel drug discovery
开发噬菌体技术精确控制肠道微生物群紊乱以促进新药研发
- 批准号:
23K18394 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of drug discovery platform for neurodegenerative diseases using new 3D culture method
利用新的3D培养方法开发神经退行性疾病药物发现平台
- 批准号:
22KJ2712 - 财政年份:2023
- 资助金额:
$ 3.84万 - 项目类别:
Grant-in-Aid for JSPS Fellows